Utilizing a Simple Method for Stoichiometric Protein Labeling to Quantify Antibody Blockade.

Area of Science:

• Biochemistry
• Molecular Biology
• Assay Development

Background:

• Ligand binding assays often use fluorescently labeled proteins generated via random lysine modification, leading to heterogeneous populations and variable binding.
• Quantitative, site-specific labeling offers a solution to improve assay accuracy and reproducibility.

Purpose of the Study:

• To present a novel, single-step method for site-specific protein labeling using 2-cyanobenzothiazole (CBT) condensation.
• To demonstrate the generation of homogeneous, quantitatively labeled growth factors with retained binding characteristics.
• To develop a new assay for quantifying antibody blockade of receptor-ligand interactions.

Main Methods:

• Site-specific labeling of N-terminal cysteine residues on three growth factors using CBT condensation.
• Development of a bioluminescence resonance energy transfer (BRET) assay to detect growth factor-receptor binding.
• Quantification of antibody blockade by measuring the decrease in BRET signal in a cellular context.

Main Results:

• The site-specific labeling method produced homogeneous populations of growth factors, unlike random lysine labeling.
• Labeled growth factors retained their native binding characteristics.
• The developed BRET assay reliably quantified antibody blockade of receptor-ligand interactions.

Conclusions:

• Site-specific labeling provides homogeneous protein populations for more accurate ligand binding assays.
• The novel BRET-based assay effectively quantifies antibody blockade in a cellular setting.
• This simple labeling method has broad potential for enhancing various ligand binding assays.